Levomepromazine vs Typical antipsychotics
Leaving the study early ‐ long term ‐ due to adverse events · patients with schizophrenia
Levomepromazine showed no clear difference in leaving the study early ‐ long term ‐ due to adverse events compared with typical antipsychotics (moderate certainty).
1 finding from 1 review
- RR 1 [0.07, 14.85]1 study · 38 participantsModerate